亚洲知识产权资讯网为知识产权业界提供一个一站式网上交易平台,协助业界发掘知识产权贸易商机,并与环球知识产权业界建立联系。无论你是知识产权拥有者正在出售您的知识产权,或是制造商需要购买技术以提高操作效能,又或是知识产权配套服务供应商,你将会从本网站发掘到有用的知识产权贸易资讯。

Method for Predicting Drug-Target Interactions and Uses for Drug Repositioning

技术优势
• Existing medications used for new therapies do not need retesting to indicate safety, thus saving drug companies time and money• The TMFS method will be able to match drugs to their targets more efficiently• In a recent study, the TMFS method predicted drug-target associations with a 91% accuracy• The TMFS method discovered that mebendazole has the structural potential to inhibit VEGFR2• The TMFS method predicted that dimethyl celecoxib can bind cadherin-11. This was later confirmed with surface plasmon resonance.Stage of DevelopmentThe TMFS method has been used to profile 3671 FDA approved/experimental drugs against 2335 human protein targets. A number of drug-target associations that have potential new disease applications have been predicted.
详细技术说明
Existing drugs have the potential to be repurposed for new therapies using a computational proteochemometric method called “train, match, fit, streamline” (TMFS). The present method takes advantage of the known structure of a drug molecule, and matches them to known structural targets of human proteins within a database to use as potential new therapies.
*Abstract
None
*Publications
Dakshanamurthy S, Issa NT, Assefnia S, Seshasayee A, Peters OJ, Madhavan S, Uren A, Brown ML, Byers SW. "Predicting new indications for approved drugs using a proteochemometric method." Journal of Medicinal Chemistry, 55: 6832-848, 2012."Repurposing Drugs: Virtually There" The Economist, 11 Aug. 2012. http://www.economist.com/node/21560236 (Accessed 24 Aug. 2012).
国家/地区
美国

欲了解更多信息,请点击 这里
移动设备